Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
What is Nemaura Medical's quote symbol?
What is the 52 week high and low for Nemaura Medical (NASDAQ: NMRD)?
How much is Nemaura Medical stock worth today?
How much is Nemaura Medical's stock price per share?
What is Nemaura Medical's Market Cap?